Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Return on Assets (2023 - 2025)

Historic Return on Assets for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to 0.35%.

  • Nuvation Bio's Return on Assets rose 5600.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 5600.0%. This contributed to the annual value of 0.98% for FY2024, which is N/A changed from last year.
  • Per Nuvation Bio's latest filing, its Return on Assets stood at 0.35% for Q3 2025, which was up 5600.0% from 0.36% recorded in Q2 2025.
  • Nuvation Bio's Return on Assets' 5-year high stood at 0.11% during Q1 2024, with a 5-year trough of 1.17% in Q1 2025.
  • Moreover, its 3-year median value for Return on Assets was 0.6% (2025), whereas its average is 0.61%.
  • Data for Nuvation Bio's Return on Assets shows a peak YoY increase of 5600bps (in 2025) and a maximum YoY decrease of -10600bps (in 2025) over the last 5 years.
  • Over the past 3 years, Nuvation Bio's Return on Assets (Quarter) stood at 0.12% in 2023, then tumbled by -744bps to 1.02% in 2024, then skyrocketed by 66bps to 0.35% in 2025.
  • Its Return on Assets stands at 0.35% for Q3 2025, versus 0.36% for Q2 2025 and 1.17% for Q1 2025.